Allena Pharmaceuticals
IPOPublic · United States · $93.0M raised
- Employees
- 51–200
- Business Model
- B2B
- Website
- allenapharma.com
- Total Funding
- $93.0M
- Last Round
- $53.0M Series CDec 2015
- Rounds
- 3
- Type
- Public
About
Allena Pharmaceuticals is a late-stage biopharmaceutical company developing first-in-class oral enzyme therapeutics.
Summary
Allena Pharmaceuticals is a Biotech company based in United States. It has raised $93.0M in total across 3 rounds, most recently a $53.0M Series C round in Dec 2015. Investors include PFM Health Sciences, HBM Partners and Bessemer VP.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2017
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...